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Bone remodelingOsteoblast recruitment during bone remodeling is obligatory to re-construct the bone resorbed by the osteoclast.
This recruitment is believed to be triggered by osteoclast products and is therefore likely to start early during the
remodeling cycle. Several osteoclast products with osteoblast recruitment potential are already known. Here we
draw the attention on the osteoblast recruitment potential of the collagen that is freshly demineralized by the
osteoclast. Our evidence is based onobservations on adult human cancellous bone, combinedwith in vitro assays.
First, freshly eroded surfaces where osteoblasts have to be recruited show the presence of non-degraded
demineralized collagen and close cell–collagen interactions, as revealed by electron microscopy, while surface-
bound collagen strongly attracts osteoblast lineage cells in a transmembrane migration assay. Compared with
other extracellular matrix molecules, collagen's potency was superior and only equaled by ﬁbronectin. Next,
themajority of the newly recruited osteoblast lineage cells positioned immediately next to the osteoclasts exhibit
uPARAP/Endo180, an endocytic collagen receptor reported to be involved in collagen internalization and cell
migration in various cell types, and whose inactivation is reported to lead to lack of bone formation and skeletal
deformities. In the present study, an antibody directed against this receptor inhibits collagen internalization in
osteoblast lineage cells and decreases to some extent theirmigration to surface-bound collagen in the transmem-
branemigration assay. These complementary observations lead to a model where collagen demineralized by os-
teoclasts attracts surrounding osteoprogenitors onto eroded surfaces, andwhere the endocytic collagen receptor
uPARAP/Endo180 contributes to this migration, probably together with other collagen receptors. This model ﬁts
recent knowledge on the position of osteoprogenitor cells immediately next to remodeling sites in adult human
cancellous bone.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
Bone remodeling renews the bone matrix through a tightly regulat-
ed process starting with resorption of old bone by osteoclasts (OCs),
then a “reversal phase”, followed by reconstruction of new bone by os-
teoblasts (OBs) [1]. It has been known for a long time that reconstruc-
tion of new bone during remodeling demands OB recruitment [1]. A
series of observations indicate that this recruitment is closely associated
with osteoclast activity [2,3], and is therefore likely to already occur dur-
ing the resorption and reversal phase. Accordingly, histomorphometry
of adult human cancellous bone revealed that virtually all the cells on), Vejle Hospital, Kabbeltoft 25,
wan.edu.eg (M.E. Abdelgawad),
. This is an open access article undereroded surfaces next to the OC are OB-lineage cells that mature during
the reversal phase [4]. Furthermore, a critical density level of these
cells appears required for the actual initiation of bonematrix deposition
[4,5].
Extensive research has addressed the origin of the osteoprogenitors
as well as the nature of the signals recruiting them to the remodeling
sites and inducingOBdifferentiation. Thebonemarrow is rich inmesen-
chymal stem cells (MSCs), and accordingly, osteoprogenitors are often
proposed to originate from the bone marrow [6]. It has been proposed
that the signals attracting the MSCs to the remodeling sites are mole-
cules released by the OCs which then diffuse into the bone marrow.
This proposal received support from cell migration assays showing
that a series of soluble cytokines, chemokines, growth factors, or other
OC products such as collagen fragments and sphingosine 1-phosphate
exert chemotaxis onMSCs or onmore mature OB-lineage cells [2,3,7,8].
However, there is also evidence for osteoprogenitors originating
from sites close to bone surfaces undergoing remodeling. The existencethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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clearly documented [5,9]. It was reported that this osteoprogenitor
layer gets the appearance of a canopy above bone remodeling sites [5],
and the absence of canopies coincides with lack of bone formation
[10–12]. It was also proposed that bone lining cells (BLCs) are able to
differentiate into bone formingOBs [13–16]. BLCs are believed to retract
to give the OC access to the bone surface [17,18], and to recolonize the
resorption site after the OC has left, like in a wound-repair process
[19,20]. This colonization may be triggered by the erosion of the bone
surface by the OC which creates new epitopes. Examples of cell migra-
tion induced by changes in the extracellular matrix (ECM) are shown
in other tissues [21,22] and are called haptotaxis when the signal is
ECM-bound, in contrast with chemotaxis when the signal is a soluble
factor [8,23]. However, the ECM peculiarities of these eroded surfaces,
deﬁned as reversal surfaces [4,24], are poorly investigated. The same
holds true for their interaction with the cells colonizing them, deﬁned
as reversal cells [4,24]. Still, close interactions of reversal cells with the
resorption zone beneath the OCs have been reported [19,25,26]. Analy-
ses at high magniﬁcation especially draw the attention on interactions
between reversal cells and demineralized collagen ﬁbers [19], suggest-
ing that these ﬁbers might be one of the signals attracting reversal
cells. Accordingly, insoluble collagen was reported to induce haptotaxis
of human and rabbit MSCs [8].
How insoluble collagen is recognized by osteoprogenitors, and
how this recognition may induce cell movement, has not been inves-
tigated. In this respect, it is of interest that OB lineage cells were re-
ported to express the collagen receptor uPARAP/Endo180, and that
inactivation of this receptor leads to impairment of bone formation
and skeletal deformities [27,28]. This receptor is able to internalize
collagen which is delivered to lysosomes via endosomal trafﬁcking
[29], whereas uPARAP/Endo180 is recycled to the plasma membrane
[30]. Importantly, endocytic recycling pathways are suspected to be
involved in cell migration [31], and accordingly, the absence of
uPARAP/Endo180 resulted in impaired migration of ﬁbroblasts con-
comitantly with deﬁcient collagen internalization [32,33]. It is also
of interest that uPARAP/Endo180-mediated collagen uptake is asso-
ciated with collagenolysis, not only at the lysosomal level, but also
at the extracellular level [34,35], and may be part of the previously
reported cleaning activity of reversal cells [19].
These data prompted us to investigate the haptotactic response of
human OB lineage cells to insoluble collagen, compared with other
ECMmolecules. We used therefore a standardized transmembrane mi-
gration assay and both human bone-derived cells (HBDCs) obtained
from bone outgrowths and adipocyte derived stem cells differentiated
into OBs (ADSC-OBs). We also addressed the mechanism of collagen-
induced haptotaxis by investigating the involvement of the endocytic
collagen receptor, uPARAP/Endo180 in this process.
Materials and methods
Cells for haptotaxis and collagen internalization assays
Human OB-like cells of two distinct origins were used to mimic re-
versal cells in vitro: 1. Primary adipocyte-derived stem cells (ADSCs)
(kit obtained from: Invitrogen, Franklin Lakes, NY, USA) were seeded
at a density of 1700 cells per bovine cortical bone slice (96-well) (IDS
Nordic, Herlev, Denmark and Boneslices.com, Jelling, Denmark) using
culture conditions and medium as described by the cell-supplier.
Culture media were refreshed after 4 days of culture. Starting from the
seventh day and for an additional 14 days ADSCs were differentiated by
supplying the culture medium with 50 μg/mL ascorbic acid, 10 mM β-
glycerophosphate and 10 nMdexamethasone. Themedia were refreshed
twice a week. Differentiation into an early osteoblastic phenotype was
veriﬁed by Q-RT-PCR where collagen type I and osteopontin expressions
were increased about 2-fold and RANKL by 5-fold, furthermore bALP
activity was increased by 5-fold. In addition, expression of MMP13 wasincreased by 17-fold. This proﬁle matches well the characteristics of a re-
versal cell model as an early osteoblastic phenotype with collagenolytic
potential. ADSCs differentiated to early OBs (ADSC-OBs) either were
used for collagen internalization assay, or were ﬂuorescently labeled
with 10 μM green Vybrant for 15 min (V12883, Molecular Probes,
Eugene, OR, USA). Labeled ADSC-OBs were detached by using 0.1% (w/
v) collagenase (Clostridium histolyticum, Wako, Tokyo, Japan) for 30 min
followed by 0.05% (v/v) trypsin–EDTA (Gibco, Invitrogen, Franklin
Lakes, NY, USA) for 10 min, and ﬁnally by mechanical detachment.
Detached ADSC-OBs were washed with excess serum, resuspended in
serum freemedium, and used for haptotaxis assays. 2. The second source
of OB-lineage cells was obtained from outgrowths from explants taken
from the proximal femur of osteoarthritis patients undergoing total
hip replacement (Danish Ethical Committee approval, project-ID: S-
20110114). The explants were cultured as previously described [36].
The outgrowing “human bone-derived cells” (HBDCs) were cultured
until conﬂuence (after 4–5 weeks), then ﬂuorescently labeled with
10 μM green Vybrant for 15min as explained for the ADSCs, and ﬁnally
detached using Accutase (PAA Laboratories, GE Healthcare, Piscataway
Township, NJ, USA) for 10 min. Detached HBDCs were resuspended in
serum free medium and used for haptotaxis assays.
Materials for haptotaxis and collagen internalization assay
The materials for haptotaxis and collagen internalization assays
were cell matrix type I-A (porcine collagen type I) (Nitta Gelatin,
Osaka, Japan); human vitronectin (BD Biosciences, San Jose, California,
USA); bovine ﬁbronectin (Wako, Tokyo, Japan); bovine serum albumin
(BSA) (Sigma-Aldrich, St. Louis, MO, USA); calf osteopontin (generous
gift from Dr. W.T. Butler, University of Texas, Houston, USA); gelatin
prepared by heating collagen type I at a concentration of 1.5 mg/mL
serum free medium for 30 min at 60 °C; and cysteine-proteinase in-
hibitor E64d dissolved in ethanol (Calbiochem, San Diego, CA, USA).
The monoclonal mouse uPARAP/Endo180 antibody 5f4 used for the
haptotaxis and internalization assays, and its isotype-matched control
anti-trinitrophenyl (TNP) antibody, and also the other monoclonal
mouseuPARAP/Endo180antibody2h9F12used for immunohistochemis-
trywere generated by the Finsen Laboratory, Rigshospitalet, Copenhagen,
Denmark [37].
Haptotaxis assay
The haptotaxis assays were performed in a multiwell 24 well insert
system (BD Falcon FluoroBlok, BD Biosciences, San Jose, California,
USA) with an 8 μmpore size membrane impervious to light. The exper-
imental procedure used was essentially as previously described [8]. The
lower side of the membrane was coated with 28 μL matrix protein dis-
solved in serum freemedium containing the same number of molecules
of collagen type I, gelatin, vitronectin, osteopontin and ﬁbronectin
(42 μg collagen type I, gelatin, or BSA, 10.5 μg vitronectin, 8.34 μg osteo-
pontin, or 28 μg ﬁbronectin). They were placed in the incubator
for 30 min at 37 °C in order for the matrix protein coating to adhere to
the transwell membrane. A 250 μL cell suspension containing 75,000
ﬂuorescently labeled ADSC-OBs or HBDCs in serum free medium was
added to the insert (upper chamber), and 750 μL of medium was
added to the lower chamber. After an overnight incubation at 37 °C
and 5% CO2 in the incubator, the migrated ADSC-OB or HBDC on
the lower surface of the transwell membrane was washed in PBS,
ﬁxed with 3.7% formaldehyde (Sigma-Aldrich, St. Louis, MO, USA) for
10 min, and washed. The membranes were carefully cut out, placed
on glass slides with their lower face up, mounted in ProLong Gold
with DAPI (Molecular Probes, Eugene, OR, USA) and stored in the dark
at 4 °C until analysis. The number of ﬂuorescently labeled cells and
nuclei on the lower face of the membranes was counted over the
whole surface using an Axio Imager Z1 microscope (Carl Zeiss, Jena,
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cells per transwell.
Collagen internalization assay
Collagen internalization in ADSC-OBs was performed essentially as
previously described [38]. In brief, bone slices with ADSC-OBs were in-
cubated with 20 μM E64d (Calbiochem, San Diego, CA) to prevent deg-
radation of internalized collagen and either 10 μg/mL uPARAP/Endo180
blocking antibody (5f4) or no antibody at 37 °C for 4 h. 20 μg/mL of
labeled collagen (Oregon green-labeled gelatin, Invitrogen, Franklin
Lakes, NY, USA) was added and cells were then incubated overnight at
37 °C to allow the cells to internalize collagen. Excess and cell surface
bound collagen ligand was removed by trypsinization for 3 min and re-
placedwith freshmedium. Bone sliceswere subsequently transferred to
a 14 mm glass dish (P35G-0-14-C MatTek, Ashland, MA, USA) and im-
aged immediately with a Zeiss LSM 510 confocal microscope. Cell out-
lines were visualized using DIC (differential interference contrast)
microscopy. Alternatively, following the overnight incubation with the
collagen ligand, ADSC-OBs were detached from the bone slices as ex-
plained previously. Serum free medium was supplemented with E64d
10 μM during all detachment steps. ADSC-OBs were then washed, and
resuspended in PBS containing 5 μg/mL WGA–Alexa 594 (wheat germ
agglutinin, Invitrogen, Franklin Lakes, NY, USA) to stain the cell surface.
Thereafter they were washed, resuspended in PBS, centrifuged onto a
coverslip using a Shandon chamber cytospin system (Thermo Scientiﬁc,
Langenselbold, Germany), ﬁxed for 10 min in 4% paraformaldehyde,
mounted onto an objective glass in ProLong Gold with DAPI (Molecular
Probes, Eugene, OR, USA) and imaged using a Zeiss LSM 780 confocal
microscope.
Histological assessment of adult human cancellous bone
Parafﬁn-embedded iliac crest biopsies from 9 patients (Danish Ethical
Committee approval, project-ID: 20010082) with no skeletal diseases
were used for immunohistochemistry. The immunohistochemical stain-
ing of uPARAP/Endo180 was performed by using a monoclonal mouse
IgG 2h9F12, which was detected with horseradish peroxidase (HPR)-
conjugated goat anti-mouse IgG1 subtype-speciﬁc secondary antibody
(Jackson Immunovision, Baltimore Pike, West Grove, PA, USA). This
immunostaining was conducted as a double immunostaining, so as to
also localize the OC marker Tartrate Resistant Phosphatase (TRAcP).
This procedure was previously described [10]. Reversal cells and bone
lining cells (BLCs) were recognized by their position on respectively bro-
ken or unbroken lamellae, which were visualized in polarized light. All
the ﬁrst and second uPARAP/Endo180-positive reversal cells or BLCs
neighboring to an OC (see Fig. 3A) were quantiﬁed. The results were
expressed as the percentage of reversal cells or BLCs which were stained
positive for uPARAP/Endo180.
Transmission electron microscopy (EM) on bone biopsies from pri-
mary hyperparathyroidism (PHPT) patients (Danish Ethical Committee
approval, project-ID: S-20070121) was performed as previously de-
scribed [5]. PHPT biopsies were chosen due to their increased activation
frequency of bone remodeling which makes the detection of bone
remodeling sites at the EM level easier.
Cytochemistry of osteoclasts cultured on bone slices
OCswere generated from buffy coats donated by healthy volunteers
(Danish Ethical Committee approval, project-ID: 2007-0019) and cul-
tured on bovine bone slices (IDS Nordic, Herlev, Denmark) for 72 h as
previously described [39] They were processed for staining of collagen
and actin as reported [40]. Collagen was stained with a rabbit antibody
directed against collagen type 1 (ab34710 Abcam, Cambridge, UK),
followed by an incubation with an anti-rabbit antibody (Alexa Flour
568, Invitrogen, Franklin Lakes, NY, USA). F-actin was stained withphalloidin (Alexa Flour 488, Invitrogen). Confocal pictures were taken
using an Olympus FluoView FV10i (Olympus Corporation, Shinjuku,
Tokyo, Japan).
Statistical analyses of the data
For in vitro haptotaxis experiments, all experimentswere performed
at least twice. The parameters measured in the different conditions
were compared using unpaired Student's t-test when the data were
Gaussian distributed; otherwise Mann–Whitney Rank sum test was
used. While in the case of in vivo quantiﬁcation of uPARAP/Endo180,
paired Student's t-test was used when comparing Gaussian distributed
differences between two parameters within the same patient. Results
are represented as mean± standard deviation (SD). All graphs and sta-
tistics were done using GraphPad Prism version 5 (GraphPad Software,
San Diego, California, USA). P b 0.05 was considered statistically signiﬁ-
cant. The ﬁnal ﬁgures were assembled using the CorelDraw package
(x4) (Corel Corporation, Ottawa, Ontario, Canada).
Results
Non-degraded demineralized collagen I is present on eroded bone surfaces
The analysis of eroded surfaces at high resolution shows OCs and
mononucleated cells at their immediate vicinity, as reported by others
[25]. Recent studies showed that these cells belong to the OB lineage
[4], and were called reversal cells [4,24]. The alterations made by the
OC on the bone surface may represent signals attracting these cells
after the departure of the OC. Figs. 1A–D show that non-digested
demineralized collagen represents one of these alterations, since it is
present beneath both the OC and the reversal cells. The likelihood that
denuded collagen is left behind the OC when it moves away from the
resorption site is also supported by the presence of demineralized
collagen at the back-side of the resorption trenches made by OCs
cultured on bone slices (Figs. 1F, G). Furthermore, we found evidence
of enwrapment of these collagen ﬁbers by the plasma membrane of
these reversal cells, and the plasma membrane was more electron-
dense at these enwrapment sites (Fig. 1E). This indicates active interac-
tions between reversal cells and collagen. Together, this suggests that
the collagen demineralized by the OC might serve as a signal attracting
reversal cells.
Collagen type I exerts a high haptotactic effect on osteoblast-lineage cells
compared with other ECM molecules
In order to test the aforementioned hypothesis, we developed an
in vitro model where ADSC-OBs and HBDCs were seeded on the
upper-surface of a porous membrane whose lower surface was coated
with native collagen, or with osteopontin, vitronectin, or ﬁbronectin,
which are ECM molecules that might be relevant to eroded surfaces
generated in vivo. As control molecules, we also included BSA and gela-
tin representing denatured collagen. Fig. 2 shows that during an over-
night culture, cells migrated to the lower surface of the membrane,
and thatmigration levels were signiﬁcantly higher in response to native
collagen and ﬁbronectin, compared to all other proteins, including gela-
tin. Fibronectin was actually as efﬁcient as collagen. Interestingly, the
migration patterns of ADSCs-OBs and HBDCs were similar.
The endocytic collagen receptor uPARAP/Endo180 is frequently present
in early reversal cells, and is involved in haptotaxis of osteoblast lineage
cells to collagen
The haptotactic response to collagen shows that these cells recog-
nize collagen and suggests the involvement of a collagen receptor. As
explained in the Introduction, uPARAP/Endo180 is a collagen receptor
involved in cell migration, associated with clathrin-coated pits, is
Fig. 1. Non-degraded demineralized collagen I is present on eroded bone surfaces. (A) Electron micrograph showing an eroded surface with an osteoclast (OC) and two reversal cells
(Rv.C). (B, C, D) Higher magniﬁcation of the boxed areas shown in (A). The interface between the bone-facing surface of the OC or reversal cells and the eroded surface shows
demineralized collagen ﬁbers (dc) on top of black mineralized ﬁbers (mc). Gradual decrease in density of mineral indicates the presence of OC activity [19]. Note the presence of cellular
extensions of reversal cells in (C) (blue arrows). (E) Higher magniﬁcation of the boxed area in (C). Note the enwrapment (asterisk) of demineralized collagen ﬁbers (dc) as well as the
electron dense plasma membrane at the enwrapment site. (F) Confocal image of an OC making a resorption trench on a bone slice, where F-actin is stained in green, non-degraded
demineralized collagen in red and nuclei in blue with DAPI. The white arrow indicates the direction of movement of the OC. (G) The same view as in (F), showing only red non-
degraded demineralized collagen left by the OC at the backside of the resorption trench.
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an unknown mechanism. Fig. 3A shows immunoreactivity for
uPARAP/Endo180 in OC-surrounding cells on the bone surface. These
cells can be categorized into BLCs on quiescent surfaces, and early rever-
sal cells which have colonized eroded surfaces. We quantiﬁed the pro-
portion of uPARAP/Endo180-positive cells in each of these categories,
limiting our analysis to the two surface cells at each side of the OCs.
This quantiﬁcation revealed an average of 75% of uPARAP/Endo180-
positive early reversal cells, and an average of 50% of uPARAP/
Endo180-positive BLCs proximal to OCs (Fig. 3B). These measurements
show a signiﬁcant increase in uPARAP/Endo180 levels in early reversal
cells compared to BLCs, and are compatible with a role of uPARAP/
Endo180 in early reversal cells.
In order to investigate whether the presence of uPARAP/Endo180 in
these reversal cells might reﬂect a role in haptotaxis to collagen, weFig. 2. Higher haptotactic migration of ADSCs-OBs (A) and HBDCs (B) towards collagen type I a
collagen type 1 (Col1), gelatin (Gel), BSA, ﬁbronectin (FN), vitronectin (VN), and osteopontin (
number ofmigrated cells perwell, counted in 6 (A) or 4 (B)wells. The haptotactic responses to c
sum test. ns: not signiﬁcant, *P b 0.05, **P b 0.01.performed the haptotaxis assay in the presence and absence of an anti-
body, 5f4, which has been shown to decrease uPARAP/Endo180 avail-
ability [38]. Fig. 4 shows that compared to a control isotype antibody,
5f4 reduced the migration of both ADSC-OBs and HBDCs to the
collagen- and gelatin-coated surfaces, but the effect was statistically
most signiﬁcant for collagen. The level of reduction was about 30% in
the case of collagen, and a dose response curve showed that the present
concentration of 5f4 corresponds to amaximum inhibition (not shown).
These observations suggest that uPARAP/Endo180 contributes to some
degree to migration towards native collagen.
uPARAP/Endo180 is involved in collagen internalization
Nextwe investigated themechanism responsible for thepromigratory
role of uPARAP/Endo180. One of the possible mechanisms relates to itsnd ﬁbronectin, compared with other extracellular matrix proteins. The migration towards
OPN) was compared using the haptotaxis assay. Each bar represents themean± SD of the
ollagen and the othermatrixmoleculeswere compared by using theMann–Whitney Rank
Fig. 3. The endocytic collagen receptor uPARAP/Endo180 is expressed in reversal cells and
BLCs in vivo. (A) Histological appearance of double immunostained sectionswithOCmarker
TRAcP (red) and collagen receptor uPARAP/Endo180 (brown). uPARAP/Endo180-positive
BLCs (black arrows) on a quiescent surface, and uPARAP/Endo180-positive reversal cells
(red arrows) are shown on an eroded surface at both sides of a TRAcP-positive OC (asterisk).
(B) The two bone surface cells at each of the sides of an OC (see A) were sorted in BLCs
and reversal cells, dependingonwhether theywere onunbrokenor broken lamellae, respec-
tively (see Materials and methods). The percentage of those expressing uPARAP/Endo180
was calculated for each biopsy. Each of these percentages is shown by a dot. The horizontal
bars are themeans±SDof the 9 determinations corresponding to each biopsy. The percent-
ages of uPARAP/Endo180-positive BLCs and Rv.Cswere compared by using the paired t-test.
*P b 0.05.
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which reduces uPARAP/Endo180 bioavailability has been shown to
prevent collagen uptake in a number of cell types [38]. Here we show
that ADSCs-OBs incubated with collagen readily internalized collagen,
but not if the incubation was performed in the presence of 5f4 (Fig. 5).
Thus, 5f4 affects both collagen internalization and haptotaxis to collagen.
Discussion
OB recruitment is mandatory for coupling bone resorption to forma-
tion during bone remodeling. The ﬁrstmanifestation of this recruitment
is the colonization of eroded surfaces by reversal cells, which are actual
progenitors of bone forming OBs [4,5]. Cell recruitment is determined
by a number of environmental-speciﬁc activities, all strictly coordinated
in time and space. Most of these activities are poorly known in the case
of the OB recruitment occurring during bone remodeling. Herewe focus
on insoluble factors exposed by the OC on eroded bone surfaces,
and propose that demineralized collagen is one of the agents attracting
reversal cells from sites contiguous to the resorbed bone surface, as
shown in the model of Fig. 6. In this way, BLCs may recolonize the
resorbed bone surface, like in a wound-repair process [20,22]. Our pro-
posal is based on complementary observations: presence of collagen atfreshly eroded surfaces where reversal cells have to be recruited; prev-
alence of the collagen receptor uPARAP/Endo180 on these reversal cells;
actual ability of collagen to induce recruitment of OB lineage cells; and
involvement of uPARAP/Endo180 in this process.
Demineralized collagen proves to be present in the resorption zone
of resorbing OCs, and to be associated with reversal cells. These features
were previously already reported in adult rabbit cancellous bone and in
mouse calvaria [19,26]. They are now also shown in adult human
cancellous bone. Of note, the presence of non-degraded demineralized
collagen in resorption lacunae is a logical consequence of the mecha-
nism of OC bone resorption [41]. This mechanism consists in solubiliza-
tion of mineral and degradation of collagen only once collagen is
uncovered by demineralization. Importantly, both mineral solubiliza-
tion and cathepsin K-mediated collagen degradation require acidiﬁca-
tion, which means that once the OC stops acidiﬁcation, the local raise
in pH renders the acid-requiring cathepsin K ineffective for degrading
the freshly demineralized collagen. Accordingly, pit assays show that
the rate of degradation of collagen by isolated OCs proves to be slower
than the rate of solubilization of mineral [42]. The reason why collagen
left-over is often overlooked in vivo is that the surrounding cells are
in close contact with the resorption area [19,25] and contribute to
quickly removing this collagen left-over through a mechanism involv-
ing MMPs, which do not require acidic pH [19,41,43]. As explained
in the Introduction, many of these so-called reversal cells are likely to
originate from BLCs [13–16] and progressively mature in bone forming
OBs [4].
The present transmembrane assays indicate that matrix-bound
collagen is able to induce recruitment of OB-lineage cells. Compared
with other ECM molecules, including osteopontin which is typical of
reversal surfaces [44], collagen's potency for haptotaxis was superior
and equaled only by ﬁbronectin. The same migration pattern was
obtained with the two OB cell types used in our assays, one of which
consists of outgrowths from bone surfaces of human biopsies which
are rich in BLCs, i.e. one of the cell types suspected to be recruited on
eroded surfaces (see Introduction and Fig. 6). Our data are also in line
with those of Thibault et al. [8], who showed similar relative haptotactic
efﬁciency of bound collagen, ﬁbronectin, and vitronectin towards
human MSCs. Thus, matrix-bound collagen proves to be an effective
haptoattractant, irrespectively of the type of OB lineage cell and of the
laboratory where the experiments were performed.
Of note, the relevance of this in vitro observation is supported by the
close physical proximity between the OC resorption zone and the sur-
rounding cells as shown in Fig. 1 and in other reports [19,25]. However,
this relevance is stressed even more by in vivo studies where excessive
amounts of demineralized collagen were allowed to accumulate in the
OC resorption zone. Treatment of rabbits with the cathepsin K inhibitor
odanacatib resulted in impaired collagen degradation and increased re-
versal cell recruitment, as based on measurements of collagen accumu-
lation in the resorption zone and quantiﬁcations of densities of reversal
cells on bone surfaces of the vertebrae [26]. Previously, it was stressed
that inhibition of cathepsin K in mouse bone explants resulted in im-
paired OC collagen degradation and active recruitment of reversal cells
closely interacting with this collagen [19]. This collagen-induced rever-
sal cell recruitmentmay be one of the explanationswhy bone formation
is favored in situationswhere cathepsin K activity is decreased, either by
odanacatib [45], or by increasing the pH of the OC–bone interface [46].
An important issue is the mechanism whereby collagen might in-
duce recruitment of reversal cells. Collagen is not only a structural com-
ponent of the matrix, but also a well-known signaling molecule able to
deﬁne cell behavior through speciﬁc collagen receptors [47]. In the pres-
ent study, we made several observations ﬁtting the hypothesis that the
endocytic collagen receptor uPARAP/Endo180 contributes to themech-
anism inducing recruitment of reversal cells. We showed that uPARAP/
Endo180 is expressed in the majority of the reversal cells next to OCs
and to a lesser extent in BLCs. uPARAP/Endo180 was also recently
reported in the canopy cells covering the OCs and believed to be a
Fig. 4. Anti-uPARAP/Endo180 mAb 5f4 inhibits the haptotactic migration of ADSCs-OBs (A) or HBDCs (B) towards collagen type I. The haptotactic migration towards collagen type I and
gelatinwas measured as explained in the legend of Fig. 2, in the presence or absence of anti-uPARAP/Endo180 5f4 (20 μg/mL) or of its isotypematched control antibody anti-TNP 20 μg/mL.
Prior to the assay, the cells were already preincubated with the antibodies for 30 min at 37 °C. Between two and four experiments were performed, each with at least four cultures per con-
dition. The graphs show the pooled data of all experiments, as number ofmigrations normalized to the number ofmigrations obtained in the presence of the control antibody.Migration num-
bers did not cluster depending on the experiments. Each dot represents the number ofmigrated cells in one culture-well. The horizontal bars represent the mean ± SD of the number of
migrated cells in the respective experimental conditions. The haptotactic responses in these different conditions were compared by using the Mann–Whitney Rank sum test,
*P b 0.05; **P b 0.01; ***P b 0.001; ns = not signiﬁcant.
186 M.E. Abdelgawad et al. / Bone 67 (2014) 181–188reservoir of osteoprogenitors [48]. Thus uPARAP/Endo180 expression
coincides with the cell population involved in colonization of eroded
surfaces and collagen cleaning [19,41,43]. Furthermore, we observed
clathrin-coated pits in the plasma membrane of reversal cells exactly
at the sites of collagen enwrapment, and uPARAP/Endo180 is known
to be associated with clathrin-coated pits in the plasma membrane
[49]. Furthermore, we show that an antibody preventing recycling ofFig. 5. Anti-uPARAP/Endo180 mAb 5f4 inhibits internalization of ﬂuorescently-labeled
collagen by ADSCs-OBs. ADSC-OBs on bone slices were incubated with green-labeled
collagen in the absence (1, 3) and presence (2, 4) of uPARAP/Endo180 blocking antibody
5f4 10 μg/mL. (A) Confocal images of the cells on the bone slices were taken immediately
after incubation. The cell outlines were visualized with DIC. (B) Confocal images of the
cells after detachment and visualization of nuclei with DAPI (blue) and the cell outlines
with WGA–Alexa 594 (red). In (A) and (B) collagen internalization (green) is seen in
the absence of anti-uPARAP/Endo180 (1, 3), but not in its presence (2, 4). In (B), cross-
sections at the level of the indicated axes were reconstructed from the stack of horizontal
sections. Note the green signal appears intracellular whatever the direction of the section.uPARAP/Endo180 to the plasma membrane reduces the migration of
OB-lineage cells to immobilized collagen in the transmembrane assay.
This holds true for the two OB cell types we tested. The combination
of these in vivo and in vitro observations makes us conclude that
uPARAP/Endo180 contributes to reversal cell recruitment. Future re-
search should address whether this role contributes to impaired bone
formation and skeletal deformities induced by the absence of uPARAP/
Endo180 [27,28].
How uPARAP/Endo180 is involved in migration is far from clear [29,
30,32,50,51]. It can be speculated that this involvement relates to
cell adherence, clustering of critical plasma membrane factors to the
points where the cell contacts collagen, or activation of an endocytic
recycling pathway, since endocytic recycling is suspected to be involved
in cell migration [31]. As explained in the Introduction, the latter possi-
bility was particularly tempting to consider because early reversal cells
colonizing resorption lacunae also clear eroded surfaces of collagen
remnants [19]. Thus, we had reasoned that uPARAP/Endo180 could
perhaps support at the same time two functions required at this step
of the remodeling cycle: OB recruitment and removal of collagen rem-
nants. However, even if we could show that OB lineage cells internalize
collagen through uPARAP/Endo180, other observations indicate the ab-
sence of a strict link between collagen internalization and migration.
Importantly in this respect, denatured collagen (i.e. gelatin) is much
less efﬁcient than native collagen in attractingOBs (Fig. 2), although gel-
atin is more efﬁciently internalized by uPARAP/Endo180 compared
to native collagen [34]. The importance of the native characteristics of
collagen might rather indicate a link betweenmigration and cell adher-
ence, since uPARAP/Endo180-mediated cell adherence was reported to
require a triple helical conformation of collagen [52].
Another important conclusion of this study is that additional colla-
gen receptors appear to be involved in the colonization of the resorption
site by reversal cells, since anti-uPARAP/Endo180 was far from provid-
ing a full inhibition of migration. β1 integrins and the discoidin domain
receptors (DDR) are examples of other collagen receptors present in OB
lineage cells [53,54]. A cooperation between β1 integrins and uPARAP/
Endo180 has been reported both for collagen uptake [35] and for cell
adherencewhere uPARAP/Endo180was only involved as an early mod-
ulator [32]. β1 integrins and DDRs have been implicated in cell spread-
ing, migration and adhesion, all aspects that might relate to haptotaxis
to demineralized collagen [55]. Interestingly, these collagen receptors
Fig. 6.Model for recruitment of Rv.Cs into vacated resorption lacunae. The scheme shows a top view of a bone surface (gray). The access of the OC (pink) to the bonematrix requires re-
traction of the BLCs (pale blue). Once the OC has resorbed and moves away, the new epitopes exposed on the eroded surface (red) contribute to initiate a series of steps leading to bone
formation. The ﬁrst step is cell recruitment. The cells colonizing the resorbed surface are called reversal cells (bright blue), and include BLCs and osteoprogenitors from other sources (not
shown in the ﬁgure) [5]. We showhere that demineralized collagen (red) left behind by the OC contributes in driving this recruitment. Furthermore, this collagen-driven process appears
to involve the endocytic collagen receptor uPARAP/Endo180 (orange). After this recruitment step, local signals will induce speciﬁc activities making progressively the surface of the bone
matrix propitious to bone formation (purple), and allowing maturation of the reversal cells into mature bone forming OBs [4].
187M.E. Abdelgawad et al. / Bone 67 (2014) 181–188require native collagen characteristics [55], and this is in line with
the strong haptotaxis to collagen compared with gelatin shown in
the present study. Of note, the absence of DDRs also results in skeletal
abnormalities [55]. These data indicate the need of investigating to
what extent other collagen receptors are involved in the colonization
of resorption sites by reversal cells.
In summary, it is often proposed that chemoattractants diffusing
into the bone marrow recruit osteoprogenitors to the bone surface [2,
3,7,8]. Herewe show that demineralized collagen generated byOCs rep-
resents a likely signal attracting osteoprogenitors positioned contigu-
ously to bone remodeling sites [5,9–16]. We also suggest that uPARAP/
Endo180 is one of the receptors involved in this process (Fig. 6). The
present study should open the way to investigate the possible involve-
ment of other receptors and matrix-bound molecules triggering this
recruitment.
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